Cancer research in the U.S. is backed by a complex system of interdependent funding. Partners include academia, pharmaceutical companies, biotechnology start-ups, federal agencies and private foundations. These groups rely heavily on each other and, when one struggles, the entire system suffers.

People in Flint are concerned about elevated cancer rates, particularly multiple myeloma, and possible links to environmental exposures where they live, work, and play. For many in the community, a lack of high-quality reporting on cancer rates in the wake of the Flint water crisis can be highly distressing, worrisome, and frustrating.

Four dedicated researchers from Michigan State University have received grants totaling more than $3 million from the American Cancer Society, or ACS, to find new ways to prevent, detect, treat and help patients survive colorectal, breast and cervical cancer.

More than 250 researchers with Henry Ford Health + Michigan State University Health Sciences receive funding from federal agencies as well as other sources that supports their research focused on better diagnosis and treatment for cancer patients. They bring together diverse expertise across disciplines and, often, one advancement contributes to another.

Teresa K. Woodruff joined an elite group of Americans who have received two national medals of honor when President Joe Biden announced the latest recipients of the National Medal of Science on Jan. 3.

Michigan State University researchers have developed a virtual reality curriculum to prepare health care professionals and students for the complexities of caring for patients with tracheostomies and laryngectomies.